Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(2 sites)
China
The First Affiliated Hospital of Henan University of Science and Technology, Luoyang, Henan Zhejiang Cancer Hospital, Hangzhou, Zhejiang